• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Brightcove Inc.

    2/18/25 12:51:00 PM ET
    $BCOV
    EDP Services
    Technology
    Get the next $BCOV alert in real time by email
    15-12G 1 d926744d1512g.htm 15-12G 15-12G

    As filed with the Securities and Exchange Commission on February 18, 2025

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 15

     

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934.

    Commission File Number: 001-35429

     

     

    BRIGHTCOVE INC.

    (Exact name of registrant as specified in its charter)

     

     

    281 Summer Street

    Boston, Massachusetts 02210

    (888) 882-1880

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

    Common Stock, par value $0.001 per share

    (Title of each class of securities covered by this Form)

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1)

      ☒

    Rule 12g-4(a)(2)

      ☐

    Rule 12h-3(b)(1)(i)

      ☒

    Rule 12h-3(b)(1)(ii)

      ☐

    Rule 15d-6

      ☐

    Rule 15d-22(b)

      ☐

    Approximate number of holders of record as of the certification or notice date:

    Common Stock, par value $0.001 per share: 1*

     

     

     


    * Explanatory Note: Effective as of February 4, 2025, pursuant to that certain Agreement and Plan of Merger, dated as of November 24, 2024, by and among Brightcove Inc., a Delaware corporation (“Brightcove”), Bending Spoons US Inc., a Delaware corporation (“Parent”), Bending Spoons S.p.A., an Italian societá per azioni, and Blossom Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into Brightcove, with Brightcove surviving as a wholly-owned subsidiary of Parent.

    On February 5, 2025, Nasdaq filed a Form 25 to remove Brightcove’s common stock, par value $0.001 per share, from listing and registration pursuant to 17 CFR 240.12d2-2(a)(3).


    Pursuant to the requirements of the Securities Exchange Act of 1934, Brightcove Inc., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

    Date: February 18, 2025

     

    Brightcove Inc.

    By:

     

    /s/ John Wagner

    Name:

     

    John Wagner

    Title:

     

    Chief Financial Officer

    Get the next $BCOV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BCOV

    DatePrice TargetRatingAnalyst
    11/5/2024$3.50Hold → Buy
    Lake Street
    7/31/2023Hold → Buy
    Lake Street
    2/13/2023$8.00 → $10.00Neutral → Buy
    Rosenblatt
    9/9/2022$8.00Neutral
    Rosenblatt
    2/17/2022$14.00 → $9.00Buy → Hold
    Lake Street
    10/28/2021$23.00Outperform → Market Perform
    Northland Capital
    10/28/2021Outperform → Market Perform
    Northland Capital Markets
    More analyst ratings